PreprintAll rights reservedbioRxiv
Allosteric covalent inhibition of cereblon through cryptic cysteine targeting
- 1The Scripps Research Institute
Related
- Expanding Macrocyclic Topology through Cysteine-to-N-Terminal Cyclisation Enables Covalent Peptide Inhibitor Discovery
- Switching from orthosteric to allosteric inhibition: Discovery of N-aryl-1H-azaindole-derived allosteric
- Orthosteric and allosteric inhibition of the brain V-ATPase outside the alternating-access cycle.
- Allosteric inhibition of human mitochondrial ClpP by hijacking the dordaviprone (ONC201) binding site
- Covalent Targeting of the SKP1-βTrCP Interface Activates NRF1/2 Signaling
BibTeX
@misc{rizvi2026allosteric,
title = {{Allosteric covalent inhibition of cereblon through cryptic cysteine targeting}},
author = {Z. Rizvi and B. E. Nordin and K. T. Symons and K. A. Baltgalvis and D. S. Weinstein and M. P. Patricelli and G. Simon and G. C. Lander},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.10.758245},
url = {https://www.biorxiv.org/content/10.64898/2026.10.10.758245v1},
}
RIS
TY - UNPB
TI - Allosteric covalent inhibition of cereblon through cryptic cysteine targeting
AU - Z. Rizvi
AU - B. E. Nordin
AU - K. T. Symons
AU - K. A. Baltgalvis
AU - D. S. Weinstein
AU - M. P. Patricelli
AU - G. Simon
AU - G. C. Lander
PY - 2026
DA - 2026/10/10
PB - bioRxiv
DO - 10.64898/2026.10.10.758245
UR - https://www.biorxiv.org/content/10.64898/2026.10.10.758245v1
ER -